BAKER BROS. ADVISORS LP has filed 318 insider transactions across 19 companies since January 2023.
Most recent transaction: a grant/award of 421 shares of INCYTE CORP ($INCY) on March 31, 2026.
Activity breakdown: 131 open-market purchases and 12 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 421 | $0.00 | 28,782,091.0000 | 200,700,000 | 0.00% | 0.00% |
| March 31, 2026 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 421 | $0.00 | 3,411,412.0000 | 200,700,000 | 0.01% | 0.00% |
| Jan. 12, 2026 | DBV Technologies S.A. | $DBVT | BAKER BROS. ADVISORS LP | Not found | M | Second Pre-Funded Warrant | 25005240 | $0.00 | 25,005,240.0000 | 169,113,619 | 9999.99% | 14.79% |
| Jan. 12, 2026 | DBV Technologies S.A. | $DBVT | BAKER BROS. ADVISORS LP | Not found | M | Second Pre-Funded Warrant | 2299656 | $0.00 | 2,299,656.0000 | 169,113,619 | 9999.99% | 1.36% |
| Jan. 12, 2026 | DBV Technologies S.A. | $DBVT | BAKER BROS. ADVISORS LP | Not found | M | BS Warrant | 25005240 | $0.00 | 0.0000 | 169,113,619 | 100.00% | 14.79% |
| Jan. 12, 2026 | DBV Technologies S.A. | $DBVT | BAKER BROS. ADVISORS LP | Not found | M | BS Warrant | 2299656 | $0.00 | 0.0000 | 169,113,619 | 100.00% | 1.36% |
| Jan. 2, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | A | Share Option (Right to Buy) | 38000 | $0.00 | 38,000.0000 | 69,303,746 | 9999.99% | 0.05% |
| Jan. 2, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | A | American Depositary Shares | 19000 | $0.00 | 937,483.0000 | 69,303,746 | 2.07% | 0.03% |
| Jan. 2, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | A | Share Option (Right to Buy) | 38000 | $0.00 | 38,000.0000 | 69,303,746 | 9999.99% | 0.05% |
| Jan. 2, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | A | American Depositary Shares | 19000 | $0.00 | 10,018,674.0000 | 69,303,746 | 0.19% | 0.03% |
| Dec. 31, 2025 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 328 | $0.00 | 28,781,670.0000 | 201,429,000 | 0.00% | 0.00% |
| Dec. 31, 2025 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 328 | $0.00 | 3,410,991.0000 | 201,429,000 | 0.01% | 0.00% |
| Dec. 18, 2025 | Kodiak Sciences Inc. | $KOD | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 217428 | $23.00 | 1,560,414.0000 | 53,048,428 | 16.19% | 0.41% |
| Dec. 18, 2025 | Kodiak Sciences Inc. | $KOD | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 2391268 | $23.00 | 18,358,772.0000 | 53,048,428 | 14.98% | 4.51% |
| Dec. 11, 2025 | Denali Therapeutics Inc. | $DNLI | BAKER BROS. ADVISORS LP | Not found | P | $0.01 Prefunded Warrants | 2095191 | $17.49 | 25,996,310.0000 | 172,421,492 | 8.77% | 1.22% |
| Dec. 11, 2025 | Denali Therapeutics Inc. | $DNLI | BAKER BROS. ADVISORS LP | Not found | P | $0.01 Prefunded Warrants | 190523 | $17.49 | 2,335,469.0000 | 172,421,492 | 8.88% | 0.11% |
| Dec. 11, 2025 | Kymera Therapeutics, Inc. | $KYMR | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 1838621 | $86.00 | 7,955,916.0000 | 87,300,286 | 30.06% | 2.11% |
| Dec. 11, 2025 | Kymera Therapeutics, Inc. | $KYMR | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 167192 | $86.00 | 701,326.0000 | 87,300,286 | 31.30% | 0.19% |
| Nov. 20, 2025 | Entrada Therapeutics, Inc. | $TRDA | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 1213 | $9.07 | 380,152.0000 | 41,462,567 | 0.32% | 0.00% |
| Nov. 20, 2025 | Entrada Therapeutics, Inc. | $TRDA | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 13082 | $9.07 | 4,691,392.0000 | 41,462,567 | 0.28% | 0.03% |
| Nov. 20, 2025 | Entrada Therapeutics, Inc. | $TRDA | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 1186 | $9.07 | 381,338.0000 | 41,462,567 | 0.31% | 0.00% |
| Nov. 20, 2025 | Entrada Therapeutics, Inc. | $TRDA | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 13386 | $9.07 | 4,678,310.0000 | 41,462,567 | 0.29% | 0.03% |
| Nov. 10, 2025 | Entrada Therapeutics, Inc. | $TRDA | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 2947 | $7.22 | 4,529,969.0000 | 41,462,567 | 0.07% | 0.01% |
| Nov. 10, 2025 | Entrada Therapeutics, Inc. | $TRDA | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 267 | $7.22 | 366,724.0000 | 41,462,567 | 0.07% | 0.00% |
| Nov. 10, 2025 | Entrada Therapeutics, Inc. | $TRDA | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 25364 | $7.21 | 4,527,022.0000 | 41,462,567 | 0.56% | 0.06% |
| Nov. 10, 2025 | Entrada Therapeutics, Inc. | $TRDA | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 2296 | $7.21 | 366,457.0000 | 41,462,567 | 0.63% | 0.01% |
| Nov. 12, 2025 | Entrada Therapeutics, Inc. | $TRDA | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 11494 | $7.95 | 4,664,924.0000 | 41,462,567 | 0.25% | 0.03% |
| Nov. 12, 2025 | Entrada Therapeutics, Inc. | $TRDA | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 1040 | $7.95 | 378,939.0000 | 41,462,567 | 0.28% | 0.00% |
| Nov. 12, 2025 | Entrada Therapeutics, Inc. | $TRDA | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 80881 | $7.73 | 4,653,430.0000 | 41,462,567 | 1.77% | 0.20% |
| Nov. 12, 2025 | Entrada Therapeutics, Inc. | $TRDA | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 7321 | $7.73 | 377,899.0000 | 41,462,567 | 1.98% | 0.02% |
| Nov. 11, 2025 | Entrada Therapeutics, Inc. | $TRDA | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 30879 | $7.54 | 4,572,549.0000 | 41,462,567 | 0.68% | 0.07% |
| Nov. 11, 2025 | Entrada Therapeutics, Inc. | $TRDA | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 2795 | $7.54 | 370,578.0000 | 41,462,567 | 0.76% | 0.01% |
| Nov. 11, 2025 | Entrada Therapeutics, Inc. | $TRDA | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 11701 | $7.39 | 4,541,670.0000 | 41,462,567 | 0.26% | 0.03% |
| Nov. 11, 2025 | Entrada Therapeutics, Inc. | $TRDA | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 1059 | $7.39 | 367,783.0000 | 41,462,567 | 0.29% | 0.00% |
| Sept. 30, 2025 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 388 | $0.00 | 3,410,663.0000 | 210,530,000 | 0.01% | 0.00% |
| Oct. 1, 2025 | KALA BIO, Inc. | $KALA | BAKER BROS. ADVISORS LP | Not found | S | Common Stock | 50640 | $1.38 | 46,480.0000 | 7,042,457 | 52.14% | 0.72% |
| Sept. 30, 2025 | KALA BIO, Inc. | $KALA | BAKER BROS. ADVISORS LP | Not found | S | Common Stock | 195425 | $1.60 | 887,973.0000 | 6,513,108 | 18.04% | 3.00% |
| Sept. 30, 2025 | KALA BIO, Inc. | $KALA | BAKER BROS. ADVISORS LP | Not found | S | Common Stock | 21376 | $1.60 | 97,120.0000 | 6,513,108 | 18.04% | 0.33% |
| Sept. 30, 2025 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 388 | $0.00 | 28,781,342.0000 | 210,530,000 | 0.00% | 0.00% |
| Oct. 1, 2025 | KALA BIO, Inc. | $KALA | BAKER BROS. ADVISORS LP | Not found | S | Common Stock | 462967 | $1.38 | 425,006.0000 | 7,042,457 | 52.14% | 6.57% |
| Sept. 8, 2025 | Celcuity Inc. | $CELC | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 388 | $58.02 | 704,308.0000 | 39,449,393 | 0.06% | 0.00% |
| Sept. 8, 2025 | Celcuity Inc. | $CELC | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 4212 | $58.02 | 7,211,484.0000 | 39,449,393 | 0.06% | 0.01% |
| Sept. 8, 2025 | Celcuity Inc. | $CELC | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 151524 | $56.22 | 7,207,272.0000 | 39,449,393 | 2.15% | 0.38% |
| Sept. 8, 2025 | Celcuity Inc. | $CELC | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 13976 | $56.22 | 703,920.0000 | 39,449,393 | 2.03% | 0.04% |
| Sept. 3, 2025 | vTv Therapeutics Inc. | $VTVT | BAKER BROS. ADVISORS LP | Not found | A | Common Warrant | 2400605 | $0.00 | 2,400,605.0000 | 5,771,052 | 9999.99% | 41.60% |
| Sept. 3, 2025 | vTv Therapeutics Inc. | $VTVT | BAKER BROS. ADVISORS LP | Not found | A | Common Warrant | 221452 | $0.00 | 221,452.0000 | 5,771,052 | 9999.99% | 3.84% |
| Sept. 3, 2025 | vTv Therapeutics Inc. | $VTVT | BAKER BROS. ADVISORS LP | Not found | A | Prefunded Warrants | 2353913 | $0.00 | 5,176,974.0000 | 5,771,052 | 83.38% | 40.79% |
| Sept. 3, 2025 | vTv Therapeutics Inc. | $VTVT | BAKER BROS. ADVISORS LP | Not found | A | Prefunded Warrants | 217144 | $0.00 | 472,092.0000 | 5,771,052 | 85.17% | 3.76% |
| Sept. 3, 2025 | vTv Therapeutics Inc. | $VTVT | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 4308 | $0.00 | 12,368.0000 | 5,771,052 | 53.45% | 0.07% |
| Sept. 3, 2025 | vTv Therapeutics Inc. | $VTVT | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 46692 | $0.00 | 135,946.0000 | 5,771,052 | 52.31% | 0.81% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 5494 | $371.01 | 1,848,963.0000 | 22,080,246 | 0.30% | 0.02% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 10128 | $372.16 | 1,859,091.0000 | 22,080,246 | 0.55% | 0.05% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 767 | $357.02 | 189,865.0000 | 22,080,246 | 0.41% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 8328 | $357.02 | 1,807,428.0000 | 22,080,246 | 0.46% | 0.04% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 228 | $358.21 | 190,093.0000 | 22,080,246 | 0.12% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 2472 | $358.21 | 1,809,900.0000 | 22,080,246 | 0.14% | 0.01% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 784 | $359.39 | 190,877.0000 | 22,080,246 | 0.41% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 8514 | $359.39 | 1,818,414.0000 | 22,080,246 | 0.47% | 0.04% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 502 | $361.37 | 191,379.0000 | 22,080,246 | 0.26% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 5443 | $361.37 | 1,823,857.0000 | 22,080,246 | 0.30% | 0.02% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 515 | $362.39 | 191,894.0000 | 22,080,246 | 0.27% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 5587 | $362.39 | 1,829,444.0000 | 22,080,246 | 0.31% | 0.03% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 255 | $363.75 | 192,149.0000 | 22,080,246 | 0.13% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 2772 | $363.75 | 1,832,216.0000 | 22,080,246 | 0.15% | 0.01% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 211 | $366.30 | 192,360.0000 | 22,080,246 | 0.11% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 2289 | $366.30 | 1,834,505.0000 | 22,080,246 | 0.12% | 0.01% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 442 | $367.77 | 192,802.0000 | 22,080,246 | 0.23% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 4798 | $367.77 | 1,839,303.0000 | 22,080,246 | 0.26% | 0.02% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 131 | $368.84 | 192,933.0000 | 22,080,246 | 0.07% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 1419 | $368.84 | 1,840,722.0000 | 22,080,246 | 0.08% | 0.01% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 253 | $369.34 | 193,186.0000 | 22,080,246 | 0.13% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 2747 | $369.34 | 1,843,469.0000 | 22,080,246 | 0.15% | 0.01% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 506 | $371.01 | 193,692.0000 | 22,080,246 | 0.26% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 933 | $372.16 | 194,625.0000 | 22,080,246 | 0.48% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 2460 | $372.87 | 197,085.0000 | 22,080,246 | 1.26% | 0.01% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 26704 | $372.87 | 1,885,795.0000 | 22,080,246 | 1.44% | 0.12% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 675 | $374.43 | 197,760.0000 | 22,080,246 | 0.34% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 7325 | $374.43 | 1,893,120.0000 | 22,080,246 | 0.39% | 0.03% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 480 | $380.44 | 198,240.0000 | 22,080,246 | 0.24% | 0.00% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 5209 | $380.44 | 1,898,329.0000 | 22,080,246 | 0.28% | 0.02% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 176 | $380.78 | 198,416.0000 | 22,080,246 | 0.09% | 0.00% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 1919 | $380.78 | 1,900,248.0000 | 22,080,246 | 0.10% | 0.01% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 873 | $381.12 | 199,289.0000 | 22,080,246 | 0.44% | 0.00% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 9477 | $381.12 | 1,909,725.0000 | 22,080,246 | 0.50% | 0.04% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 105 | $382.29 | 199,394.0000 | 22,080,246 | 0.05% | 0.00% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 1136 | $382.29 | 1,910,861.0000 | 22,080,246 | 0.06% | 0.01% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 262 | $382.82 | 199,656.0000 | 22,080,246 | 0.13% | 0.00% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 2838 | $382.82 | 1,913,699.0000 | 22,080,246 | 0.15% | 0.01% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 373 | $383.79 | 200,029.0000 | 22,080,246 | 0.19% | 0.00% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 4049 | $383.79 | 1,917,748.0000 | 22,080,246 | 0.21% | 0.02% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 1248 | $385.06 | 201,277.0000 | 22,080,246 | 0.62% | 0.01% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 13545 | $385.06 | 1,931,293.0000 | 22,080,246 | 0.71% | 0.06% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 409 | $387.07 | 201,686.0000 | 22,080,246 | 0.20% | 0.00% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 4441 | $387.07 | 1,935,734.0000 | 22,080,246 | 0.23% | 0.02% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 34 | $389.00 | 201,720.0000 | 22,080,246 | 0.02% | 0.00% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 366 | $389.00 | 1,936,100.0000 | 22,080,246 | 0.02% | 0.00% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 231 | $389.89 | 201,951.0000 | 22,080,246 | 0.11% | 0.00% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 2506 | $389.89 | 1,938,606.0000 | 22,080,246 | 0.13% | 0.01% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 862 | $392.24 | 202,813.0000 | 22,080,246 | 0.43% | 0.00% |
| Aug. 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 9362 | $392.24 | 1,947,968.0000 | 22,080,246 | 0.48% | 0.04% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 177 | $353.88 | 189,014.0000 | 22,080,246 | 0.09% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 1923 | $353.88 | 1,798,184.0000 | 22,080,246 | 0.11% | 0.01% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 84 | $355.00 | 189,098.0000 | 22,080,246 | 0.04% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 916 | $355.00 | 1,799,100.0000 | 22,080,246 | 0.05% | 0.00% |
| Aug. 14, 2025 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | U | Non-Voting Common Stock | 834707 | $0.00 | 0.0000 | 61,816,099 | 100.00% | 1.35% |
| Aug. 14, 2025 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | U | Non-Voting Common Stock | 9886217 | $0.00 | 0.0000 | 61,816,099 | 100.00% | 15.99% |
| Aug. 14, 2025 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | U | Common Stock | 357048 | $0.00 | 0.0000 | 61,816,099 | 100.00% | 0.58% |
| Aug. 14, 2025 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | U | Common Stock | 3763362 | $0.00 | 0.0000 | 61,816,099 | 100.00% | 6.09% |
| June 30, 2025 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 492 | $0.00 | 28,780,954.0000 | 210,530,000 | 0.00% | 0.00% |
| June 30, 2025 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 492 | $0.00 | 3,410,275.0000 | 210,530,000 | 0.01% | 0.00% |
| June 30, 2025 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 953 | $0.00 | 3,763,362.0000 | 60,514,546 | 0.03% | 0.00% |
| June 30, 2025 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 953 | $0.00 | 357,048.0000 | 60,514,546 | 0.27% | 0.00% |
| June 30, 2025 | TScan Therapeutics, Inc. | $TCRX | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 67000 | $0.00 | 67,000.0000 | 111,990,417 | 9999.99% | 0.06% |
| June 30, 2025 | TScan Therapeutics, Inc. | $TCRX | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 67000 | $0.00 | 67,000.0000 | 111,990,417 | 9999.99% | 0.06% |
| June 30, 2025 | Kodiak Sciences Inc. | $KOD | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Options (right to buy) | 40000 | $0.00 | 40,000.0000 | 52,748,343 | 9999.99% | 0.08% |
| June 30, 2025 | Kodiak Sciences Inc. | $KOD | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Options (right to buy) | 40000 | $0.00 | 40,000.0000 | 52,748,343 | 9999.99% | 0.08% |
| June 30, 2025 | Kymera Therapeutics, Inc. | $KYMR | BAKER BROS. ADVISORS LP | Not found | P | Prefunded Warrants | 600309 | $44.00 | 10,225,962.0000 | 75,043,991 | 6.24% | 0.80% |
| June 30, 2025 | Kymera Therapeutics, Inc. | $KYMR | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 600309 | $44.00 | 6,117,295.0000 | 75,043,991 | 10.88% | 0.80% |
| June 30, 2025 | Kymera Therapeutics, Inc. | $KYMR | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 55191 | $44.00 | 534,134.0000 | 75,043,991 | 11.52% | 0.07% |
| June 30, 2025 | Kymera Therapeutics, Inc. | $KYMR | BAKER BROS. ADVISORS LP | Not found | P | Prefunded Warrants | 55191 | $44.00 | 974,192.0000 | 75,043,991 | 6.01% | 0.07% |
| June 25, 2025 | Kymera Therapeutics, Inc. | $KYMR | BAKER BROS. ADVISORS LP | Not found | A | Non-Qualified Stock Option (right to buy) | 16000 | $0.00 | 16,000.0000 | 75,043,991 | 9999.99% | 0.02% |
| June 25, 2025 | Kymera Therapeutics, Inc. | $KYMR | BAKER BROS. ADVISORS LP | Not found | A | Non-Qualified Stock Option (right to buy) | 16000 | $0.00 | 16,000.0000 | 75,043,991 | 9999.99% | 0.02% |
| June 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 1430 | $0.00 | 188,837.0000 | 22,080,246 | 0.76% | 0.01% |
| June 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 1430 | $0.00 | 1,796,261.0000 | 22,080,246 | 0.08% | 0.01% |
| June 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Options (right to buy) | 2580 | $0.00 | 2,580.0000 | 22,080,246 | 9999.99% | 0.01% |
| June 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Options (right to buy) | 2580 | $0.00 | 2,580.0000 | 22,080,246 | 9999.99% | 0.01% |
| June 12, 2025 | Prelude Therapeutics Inc | $PRLD | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 76000 | $0.00 | 76,000.0000 | 75,805,840 | 9999.99% | 0.10% |
| June 12, 2025 | Prelude Therapeutics Inc | $PRLD | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 76000 | $0.00 | 76,000.0000 | 75,805,840 | 9999.99% | 0.10% |
| June 10, 2025 | vTv Therapeutics Inc. | $VTVT | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 4000 | $0.00 | 4,000.0000 | 5,771,052 | 9999.99% | 0.07% |
| June 10, 2025 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 2518 | $0.00 | 3,409,783.0000 | 210,530,000 | 0.07% | 0.00% |
| June 10, 2025 | vTv Therapeutics Inc. | $VTVT | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 4000 | $0.00 | 4,000.0000 | 5,771,052 | 9999.99% | 0.07% |
| June 10, 2025 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Options (right to buy) | 9216 | $0.00 | 9,216.0000 | 210,530,000 | 9999.99% | 0.00% |
| June 10, 2025 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Options (right to buy) | 9216 | $0.00 | 9,216.0000 | 210,530,000 | 9999.99% | 0.00% |
| June 10, 2025 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 2518 | $0.00 | 28,780,462.0000 | 210,530,000 | 0.01% | 0.00% |
| June 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | BAKER BROS. ADVISORS LP | Not found | A | Class A Ordinary Shares | 8397 | $0.00 | 166,879.0000 | 76,145,617 | 5.30% | 0.01% |
| June 3, 2025 | Denali Therapeutics Inc. | $DNLI | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 31695 | $0.00 | 31,695.0000 | 164,473,772 | 9999.99% | 0.02% |
| June 3, 2025 | Denali Therapeutics Inc. | $DNLI | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 10565 | $0.00 | 3,415,958.0000 | 164,473,772 | 0.31% | 0.01% |
| June 3, 2025 | Denali Therapeutics Inc. | $DNLI | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 10565 | $0.00 | 336,867.0000 | 164,473,772 | 3.24% | 0.01% |
| June 3, 2025 | Denali Therapeutics Inc. | $DNLI | BAKER BROS. ADVISORS LP | Not found | A | Non-Qualified Stock Option (right to buy)uy) | 31695 | $0.00 | 31,695.0000 | 164,473,772 | 9999.99% | 0.02% |
| June 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Share Option (right to buy) | 50394 | $0.00 | 50,394.0000 | 76,145,617 | 9999.99% | 0.07% |
| June 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Share Option (right to buy) | 50394 | $0.00 | 50,394.0000 | 76,145,617 | 9999.99% | 0.07% |
| June 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | BAKER BROS. ADVISORS LP | Not found | A | Class A Ordinary Shares | 8397 | $0.00 | 2,768,496.0000 | 76,145,617 | 0.30% | 0.01% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 27586 | $0.00 | 27,586.0000 | 166,362,000 | 9999.99% | 0.02% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 27586 | $0.00 | 27,586.0000 | 166,362,000 | 9999.99% | 0.02% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 16214 | $0.00 | 3,864,487.0000 | 166,362,000 | 0.42% | 0.01% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 16214 | $0.00 | 39,571,717.0000 | 166,362,000 | 0.04% | 0.01% |
| May 21, 2025 | BeOne Medicines Ltd. | $ONC | BAKER BROS. ADVISORS LP | Not found | A | Share Option (Right to Buy) | 45500 | $0.00 | 45,500.0000 | 1,368,746,793 | 9999.99% | 0.00% |
| May 21, 2025 | BeOne Medicines Ltd. | $ONC | BAKER BROS. ADVISORS LP | Not found | A | Ordinary Shares | 21970 | $0.00 | 148,067.0000 | 1,368,746,793 | 17.42% | 0.00% |
| May 21, 2025 | BeOne Medicines Ltd. | $ONC | BAKER BROS. ADVISORS LP | Not found | A | Ordinary Shares | 21970 | $0.00 | 148,071.0000 | 1,368,746,793 | 17.42% | 0.00% |
| May 21, 2025 | BeOne Medicines Ltd. | $ONC | BAKER BROS. ADVISORS LP | Not found | A | Share Option (Right to Buy) | 45500 | $0.00 | 45,500.0000 | 1,368,746,793 | 9999.99% | 0.00% |
| May 15, 2025 | Immunocore Holdings plc | $IMCR | BAKER BROS. ADVISORS LP | Not found | A | Non-Qualified Share Option (right to buy) | 26198 | $0.00 | 26,198.0000 | 49,991,064 | 9999.99% | 0.05% |
| May 15, 2025 | Immunocore Holdings plc | $IMCR | BAKER BROS. ADVISORS LP | Not found | A | Non-Qualified Share Option (right to buy) | 26198 | $0.00 | 26,198.0000 | 49,991,064 | 9999.99% | 0.05% |
| March 31, 2025 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 487 | $0.00 | 3,407,265.0000 | 210,530,000 | 0.01% | 0.00% |
| March 31, 2025 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 487 | $0.00 | 28,777,944.0000 | 210,530,000 | 0.00% | 0.00% |
| March 31, 2025 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 953 | $0.00 | 3,762,409.0000 | 60,514,546 | 0.03% | 0.00% |
| March 31, 2025 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 953 | $0.00 | 356,095.0000 | 60,514,546 | 0.27% | 0.00% |
| March 27, 2025 | DBV Technologies S.A. | $DBVT | BAKER BROS. ADVISORS LP | Not found | A | BS Warrant | 25005240 | $0.00 | 25,005,240.0000 | 0 | 9999.99% | 0.00% |
| March 27, 2025 | DBV Technologies S.A. | $DBVT | BAKER BROS. ADVISORS LP | Not found | A | First Pre-Funded Warrant | 2299656 | $0.00 | 2,299,656.0000 | 0 | 9999.99% | 0.00% |
| March 27, 2025 | DBV Technologies S.A. | $DBVT | BAKER BROS. ADVISORS LP | Not found | A | First Pre-Funded Warrant | 25005240 | $0.00 | 25,005,240.0000 | 0 | 9999.99% | 0.00% |
| March 27, 2025 | DBV Technologies S.A. | $DBVT | BAKER BROS. ADVISORS LP | Not found | A | BS Warrant | 2299656 | $0.00 | 2,299,656.0000 | 0 | 9999.99% | 0.00% |
| March 17, 2025 | Immunocore Holdings plc | $IMCR | BAKER BROS. ADVISORS LP | Not found | S | 2.5% Convertible Senior Notes due 2030 | 137236000 | $113252773.88 | 0.0000 | 49,991,064 | 100.00% | 100.00% |
| March 17, 2025 | Immunocore Holdings plc | $IMCR | BAKER BROS. ADVISORS LP | Not found | P | American Depositary Shares | 92349 | $29.56 | 2,144,060.0000 | 49,991,064 | 4.50% | 0.18% |
| March 17, 2025 | Immunocore Holdings plc | $IMCR | BAKER BROS. ADVISORS LP | Not found | P | American Depositary Shares | 8589 | $29.56 | 178,596.0000 | 49,991,064 | 5.05% | 0.02% |
| March 17, 2025 | Immunocore Holdings plc | $IMCR | BAKER BROS. ADVISORS LP | Not found | P | American Depositary Shares | 646290 | $29.74 | 2,051,711.0000 | 49,991,064 | 45.99% | 1.29% |
| March 17, 2025 | Immunocore Holdings plc | $IMCR | BAKER BROS. ADVISORS LP | Not found | P | American Depositary Shares | 60110 | $29.74 | 170,007.0000 | 49,991,064 | 54.70% | 0.12% |
| March 17, 2025 | Immunocore Holdings plc | $IMCR | BAKER BROS. ADVISORS LP | Not found | S | 2.5% Convertible Senior Notes due 2030 | 12764000 | $10533376.12 | 0.0000 | 49,991,064 | 100.00% | 25.53% |
| March 5, 2025 | Replimune Group, Inc. | $REPL | BAKER BROS. ADVISORS LP | Not found | A | Non-Qualified Stock Option (right to buy)uy) | 64000 | $0.00 | 64,000.0000 | 83,498,892 | 9999.99% | 0.08% |
| March 5, 2025 | Replimune Group, Inc. | $REPL | BAKER BROS. ADVISORS LP | Not found | A | Non-Qualified Stock Option (right to buy)uy) | 64000 | $0.00 | 64,000.0000 | 83,498,892 | 9999.99% | 0.08% |
| Feb. 28, 2025 | BeOne Medicines Ltd. | $ONC | BAKER BROS. ADVISORS LP | Not found | S | American Depositary Shares | 671976 | $260.00 | 8,089,247.0000 | 1,368,746,793 | 7.67% | 0.05% |
| Feb. 28, 2025 | BeOne Medicines Ltd. | $ONC | BAKER BROS. ADVISORS LP | Not found | S | American Depositary Shares | 60851 | $260.00 | 751,478.0000 | 1,368,746,793 | 7.49% | 0.00% |
| Jan. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | A | Share Option (Right to Buy) | 8801 | $0.00 | 8,801.0000 | 58,207,593 | 9999.99% | 0.02% |
| Jan. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | A | American Depositary Shares | 4400 | $0.00 | 918,483.0000 | 58,207,593 | 0.48% | 0.01% |
| Jan. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | A | American Depositary Shares | 4400 | $0.00 | 9,999,674.0000 | 58,207,593 | 0.04% | 0.01% |
| Jan. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | A | Share Option (Right to Buy) | 8801 | $0.00 | 8,801.0000 | 58,207,593 | 9999.99% | 0.02% |
| Dec. 31, 2024 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 446 | $0.00 | 3,406,778.0000 | 211,763,000 | 0.01% | 0.00% |
| Dec. 31, 2024 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 1994 | $0.00 | 355,142.0000 | 60,434,161 | 0.56% | 0.00% |
| Dec. 31, 2024 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 1994 | $0.00 | 3,761,456.0000 | 60,434,161 | 0.05% | 0.00% |
| Dec. 31, 2024 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 446 | $0.00 | 28,777,457.0000 | 211,763,000 | 0.00% | 0.00% |
| Dec. 30, 2024 | KALA BIO, Inc. | $KALA | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 30620 | $6.44 | 118,496.0000 | 4,627,578 | 34.84% | 0.66% |
| Dec. 30, 2024 | KALA BIO, Inc. | $KALA | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 279939 | $6.44 | 1,083,398.0000 | 4,627,578 | 34.84% | 6.05% |
| Dec. 13, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | P | American Depositary Shares | 244587 | $13.72 | 8,970,829.0000 | 68,988,858 | 2.80% | 0.35% |
| Dec. 16, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | P | American Depositary Shares | 457631 | $15.34 | 9,995,274.0000 | 68,988,858 | 4.80% | 0.66% |
| Dec. 16, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | P | American Depositary Shares | 42369 | $15.34 | 914,083.0000 | 68,988,858 | 4.86% | 0.06% |
| Dec. 13, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | P | American Depositary Shares | 2809 | $13.50 | 790,763.0000 | 68,988,858 | 0.36% | 0.00% |
| Dec. 13, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | P | American Depositary Shares | 30241 | $13.50 | 8,666,247.0000 | 68,988,858 | 0.35% | 0.04% |
| Dec. 13, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | P | American Depositary Shares | 59995 | $13.63 | 8,726,242.0000 | 68,988,858 | 0.69% | 0.09% |
| Dec. 13, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | P | American Depositary Shares | 22722 | $13.72 | 819,058.0000 | 68,988,858 | 2.85% | 0.03% |
| Dec. 13, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | P | American Depositary Shares | 566814 | $13.80 | 9,537,643.0000 | 68,988,858 | 6.32% | 0.82% |
| Dec. 13, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | P | American Depositary Shares | 5573 | $13.63 | 796,336.0000 | 68,988,858 | 0.70% | 0.01% |
| Dec. 13, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | P | American Depositary Shares | 52656 | $13.80 | 871,714.0000 | 68,988,858 | 6.43% | 0.08% |
| Dec. 9, 2024 | BeOne Medicines Ltd. | $ONC | BAKER BROS. ADVISORS LP | Not found | S | American Depositary Shares | 33943 | $208.01 | 9,678,187.0000 | 1,376,751,873 | 0.35% | 0.00% |
| Dec. 9, 2024 | BeOne Medicines Ltd. | $ONC | BAKER BROS. ADVISORS LP | Not found | S | American Depositary Shares | 916964 | $186.50 | 8,761,223.0000 | 1,376,751,873 | 9.47% | 0.07% |
| Dec. 9, 2024 | BeOne Medicines Ltd. | $ONC | BAKER BROS. ADVISORS LP | Not found | S | American Depositary Shares | 3074 | $208.01 | 895,365.0000 | 1,376,751,873 | 0.34% | 0.00% |
| Dec. 9, 2024 | BeOne Medicines Ltd. | $ONC | BAKER BROS. ADVISORS LP | Not found | S | American Depositary Shares | 83036 | $186.50 | 812,329.0000 | 1,376,751,873 | 9.27% | 0.01% |
| Oct. 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Share Option (right to buy) | 28384 | $0.00 | 28,384.0000 | 71,726,685 | 9999.99% | 0.04% |
| Oct. 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | BAKER BROS. ADVISORS LP | Not found | A | Class A Ordinary Shares | 4730 | $0.00 | 2,760,099.0000 | 71,726,685 | 0.17% | 0.01% |
| Oct. 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | BAKER BROS. ADVISORS LP | Not found | A | Class A Ordinary Shares | 4730 | $0.00 | 158,482.0000 | 71,726,685 | 3.08% | 0.01% |
| Oct. 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Share Option (right to buy) | 28384 | $0.00 | 28,384.0000 | 71,726,685 | 9999.99% | 0.04% |
| Sept. 30, 2024 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 496 | $0.00 | 3,406,332.0000 | 225,928,000 | 0.01% | 0.00% |
| Sept. 30, 2024 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 496 | $0.00 | 28,777,011.0000 | 225,928,000 | 0.00% | 0.00% |
| Sept. 30, 2024 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 1994 | $0.00 | 353,148.0000 | 60,434,161 | 0.57% | 0.00% |
| Sept. 30, 2024 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 1994 | $0.00 | 3,759,462.0000 | 60,434,161 | 0.05% | 0.00% |
| Aug. 21, 2024 | Kymera Therapeutics, Inc. | $KYMR | BAKER BROS. ADVISORS LP | Not found | P | Prefunded Warrants | 347572 | $40.75 | 919,001.0000 | 58,365,499 | 60.83% | 0.60% |
| Aug. 21, 2024 | Kymera Therapeutics, Inc. | $KYMR | BAKER BROS. ADVISORS LP | Not found | P | Prefunded Warrants | 2246587 | $40.75 | 9,625,653.0000 | 58,365,499 | 30.45% | 3.85% |
| Aug. 20, 2024 | Kymera Therapeutics, Inc. | $KYMR | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 1 | $46.41 | 5,995,929.0000 | 58,365,499 | 0.00% | 0.00% |
| June 28, 2024 | Kodiak Sciences Inc. | $KOD | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Options (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| June 28, 2024 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 537 | $0.00 | 28,776,515.0000 | 225,928,000 | 0.00% | 0.00% |
| June 28, 2024 | Kodiak Sciences Inc. | $KOD | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Options (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| June 28, 2024 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 537 | $0.00 | 3,405,836.0000 | 225,928,000 | 0.02% | 0.00% |
| June 28, 2024 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 1994 | $0.00 | 351,154.0000 | 52,311,958 | 0.57% | 0.00% |
| June 28, 2024 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 1994 | $0.00 | 3,757,468.0000 | 52,311,958 | 0.05% | 0.00% |
| June 25, 2024 | vTv Therapeutics Inc. | $VTVT | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 983 | $0.00 | 983.0000 | 2,084,973 | 9999.99% | 0.05% |
| June 25, 2024 | vTv Therapeutics Inc. | $VTVT | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 983 | $0.00 | 983.0000 | 2,084,973 | 9999.99% | 0.05% |
| June 25, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Options (right to buy) | 2210 | $0.00 | 2,210.0000 | 0 | 9999.99% | 0.00% |
| June 25, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 1428 | $0.00 | 1,794,831.0000 | 0 | 0.08% | 0.00% |
| June 25, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 1428 | $0.00 | 187,407.0000 | 0 | 0.77% | 0.00% |
| June 25, 2024 | vTv Therapeutics Inc. | $VTVT | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 6000 | $0.00 | 6,000.0000 | 2,084,973 | 9999.99% | 0.29% |
| June 25, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Options (right to buy) | 2210 | $0.00 | 2,210.0000 | 0 | 9999.99% | 0.00% |
| June 25, 2024 | vTv Therapeutics Inc. | $VTVT | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 6000 | $0.00 | 6,000.0000 | 2,084,973 | 9999.99% | 0.29% |
| June 25, 2024 | Entrada Therapeutics, Inc. | $TRDA | BAKER BROS. ADVISORS LP | Not found | P | Warrants to purchase Common Stock | 3081303 | $14.85 | 3,081,303.0000 | 33,050,319 | 9999.99% | 9.32% |
| June 25, 2024 | Entrada Therapeutics, Inc. | $TRDA | BAKER BROS. ADVISORS LP | Not found | P | Warrants to purchase Common Stock | 285700 | $14.85 | 285,700.0000 | 33,050,319 | 9999.99% | 0.86% |
| June 17, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | C | American Depositary Shares | 2186686 | $0.00 | 8,636,006.0000 | 42,560,091 | 33.91% | 5.14% |
| June 17, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | C | Non-Voting Ordinary Shares | 2186686 | $0.00 | 17,840,603.0000 | 42,560,091 | 10.92% | 5.14% |
| June 17, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | C | Non-Voting Ordinary Shares | 196098 | $0.00 | 1,597,341.0000 | 42,560,091 | 10.93% | 0.46% |
| June 17, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | C | American Depositary Shares | 196098 | $0.00 | 787,954.0000 | 42,560,091 | 33.13% | 0.46% |
| June 14, 2024 | Prelude Therapeutics Inc | $PRLD | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 23500 | $0.00 | 23,500.0000 | 60,357,052 | 9999.99% | 0.04% |
| June 14, 2024 | Prelude Therapeutics Inc | $PRLD | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 23500 | $0.00 | 23,500.0000 | 60,357,052 | 9999.99% | 0.04% |
| June 12, 2024 | TScan Therapeutics, Inc. | $TCRX | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 47500 | $0.00 | 47,500.0000 | 65,599,858 | 9999.99% | 0.07% |
| June 12, 2024 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Options (right to buy) | 12517 | $0.00 | 12,517.0000 | 225,928,000 | 9999.99% | 0.01% |
| June 12, 2024 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 2830 | $0.00 | 3,581,276.0000 | 225,928,000 | 0.08% | 0.00% |
| June 12, 2024 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 2830 | $0.00 | 34,059,184.0000 | 225,928,000 | 0.01% | 0.00% |
| June 12, 2024 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | D | Common Stock | 175977 | $60.00 | 3,405,299.0000 | 225,928,000 | 4.91% | 0.08% |
| June 12, 2024 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | D | Common Stock | 5283206 | $60.00 | 28,775,978.0000 | 225,928,000 | 15.51% | 2.34% |
| June 12, 2024 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Options (right to buy) | 12517 | $0.00 | 12,517.0000 | 225,928,000 | 9999.99% | 0.01% |
| June 12, 2024 | TScan Therapeutics, Inc. | $TCRX | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 47500 | $0.00 | 47,500.0000 | 65,599,858 | 9999.99% | 0.07% |
| June 5, 2024 | BeOne Medicines Ltd. | $ONC | BAKER BROS. ADVISORS LP | Not found | A | Share Option (Right to Buy) | 68302 | $0.00 | 68,302.0000 | 1,357,034,547 | 9999.99% | 0.01% |
| June 5, 2024 | BeOne Medicines Ltd. | $ONC | BAKER BROS. ADVISORS LP | Not found | A | Share Option (Right to Buy) | 68302 | $0.00 | 68,302.0000 | 1,357,034,547 | 9999.99% | 0.01% |
| June 5, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Share Option (right to buy) | 38080 | $0.00 | 38,080.0000 | 70,633,023 | 9999.99% | 0.05% |
| June 5, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | BAKER BROS. ADVISORS LP | Not found | A | Class A Common Shares | 6346 | $0.00 | 2,755,369.0000 | 70,633,023 | 0.23% | 0.01% |
| June 5, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Share Option (right to buy) | 38080 | $0.00 | 38,080.0000 | 70,633,023 | 9999.99% | 0.05% |
| June 5, 2024 | BeOne Medicines Ltd. | $ONC | BAKER BROS. ADVISORS LP | Not found | A | Ordinary Shares | 32682 | $0.00 | 126,097.0000 | 1,357,034,547 | 34.99% | 0.00% |
| June 5, 2024 | BeOne Medicines Ltd. | $ONC | BAKER BROS. ADVISORS LP | Not found | A | Ordinary Shares | 32682 | $0.00 | 126,101.0000 | 1,357,034,547 | 34.98% | 0.00% |
| June 5, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | BAKER BROS. ADVISORS LP | Not found | A | Class A Common Shares | 6346 | $0.00 | 153,752.0000 | 70,633,023 | 4.31% | 0.01% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 18774 | $0.00 | 39,555,503.0000 | 163,819,000 | 0.05% | 0.01% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 18774 | $0.00 | 3,848,273.0000 | 163,819,000 | 0.49% | 0.01% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 31918 | $0.00 | 31,918.0000 | 163,819,000 | 9999.99% | 0.02% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 31918 | $0.00 | 31,918.0000 | 163,819,000 | 9999.99% | 0.02% |
| May 28, 2024 | Immunocore Holdings plc | $IMCR | BAKER BROS. ADVISORS LP | Not found | A | Non-Qualified Share Option (right to buy) | 12925 | $0.00 | 12,925.0000 | 48,888,975 | 9999.99% | 0.03% |
| May 29, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | A | Non-Voting Ordinary Shares | 1429986 | $21.42 | 1,793,439.0000 | 42,560,091 | 393.44% | 3.36% |
| May 29, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | A | Non-Voting Ordinary Shares | 15684860 | $21.42 | 20,027,289.0000 | 42,560,091 | 361.20% | 36.85% |
| May 28, 2024 | Immunocore Holdings plc | $IMCR | BAKER BROS. ADVISORS LP | Not found | A | Non-Qualified Share Option (right to buy) | 12925 | $0.00 | 12,925.0000 | 48,888,975 | 9999.99% | 0.03% |
| May 7, 2024 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | M | Common Stock | 15000 | $49.01 | 3,578,446.0000 | 225,928,000 | 0.42% | 0.01% |
| May 7, 2024 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | M | Non- Qualified Stock Options (right to buy) | 15000 | $0.00 | 0.0000 | 225,928,000 | 100.00% | 0.01% |
| May 7, 2024 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | M | Non- Qualified Stock Options (right to buy) | 15000 | $0.00 | 0.0000 | 225,928,000 | 100.00% | 0.01% |
| May 7, 2024 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | M | Common Stock | 15000 | $49.01 | 34,056,354.0000 | 225,928,000 | 0.04% | 0.01% |
| April 19, 2024 | TScan Therapeutics, Inc. | $TCRX | BAKER BROS. ADVISORS LP | Not found | P | Warrants to purchase Common Stock | 8851451 | $7.13 | 43,158,741.0000 | 65,599,858 | 25.80% | 13.49% |
| April 19, 2024 | TScan Therapeutics, Inc. | $TCRX | BAKER BROS. ADVISORS LP | Not found | P | Warrants to purchase Common Stock | 825968 | $7.13 | 4,018,678.0000 | 65,599,858 | 25.87% | 1.26% |
| April 18, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | A | Share Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 42,560,091 | 9999.99% | 0.06% |
| April 18, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | A | American Depositary Shares | 12000 | $0.00 | 591,856.0000 | 42,560,091 | 2.07% | 0.03% |
| April 18, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | A | American Depositary Shares | 12000 | $0.00 | 6,449,320.0000 | 42,560,091 | 0.19% | 0.03% |
| April 18, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | BAKER BROS. ADVISORS LP | Not found | A | Share Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 42,560,091 | 9999.99% | 0.06% |
| March 28, 2024 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 543 | $0.00 | 3,563,446.0000 | 225,928,000 | 0.02% | 0.00% |
| March 28, 2024 | Kymera Therapeutics, Inc. | $KYMR | BAKER BROS. ADVISORS LP | Not found | A | Non-Qualified Stock Option (right to buy) | 32000 | $0.00 | 32,000.0000 | 58,365,499 | 9999.99% | 0.05% |
| March 28, 2024 | Kymera Therapeutics, Inc. | $KYMR | BAKER BROS. ADVISORS LP | Not found | A | Non-Qualified Stock Option (right to buy) | 32000 | $0.00 | 32,000.0000 | 58,365,499 | 9999.99% | 0.05% |
| March 29, 2024 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 1994 | $0.00 | 349,160.0000 | 52,311,958 | 0.57% | 0.00% |
| March 29, 2024 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 1994 | $0.00 | 3,755,474.0000 | 52,311,958 | 0.05% | 0.00% |
| March 28, 2024 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 543 | $0.00 | 34,041,354.0000 | 225,928,000 | 0.00% | 0.00% |
| March 28, 2024 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 8066 | $9.62 | 347,166.0000 | 52,311,958 | 2.38% | 0.02% |
| March 26, 2024 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 22344 | $8.26 | 336,796.0000 | 52,311,958 | 7.11% | 0.04% |
| March 26, 2024 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 247656 | $8.26 | 3,638,533.0000 | 52,311,958 | 7.30% | 0.47% |
| March 27, 2024 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 1543 | $9.22 | 338,339.0000 | 52,311,958 | 0.46% | 0.00% |
| March 27, 2024 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 17101 | $9.22 | 3,655,634.0000 | 52,311,958 | 0.47% | 0.03% |
| March 27, 2024 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 761 | $9.27 | 339,100.0000 | 52,311,958 | 0.22% | 0.00% |
| March 27, 2024 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 8439 | $9.27 | 3,664,073.0000 | 52,311,958 | 0.23% | 0.02% |
| March 28, 2024 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 89407 | $9.62 | 3,753,480.0000 | 52,311,958 | 2.44% | 0.17% |
| March 21, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock Warrant (right to buy) | 970951 | $260.00 | 2,493,602.0000 | 0 | 63.77% | 0.00% |
| March 21, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | BAKER BROS. ADVISORS LP | Not found | P | Common Stock Warrant (right to buy) | 86741 | $260.00 | 212,188.0000 | 0 | 69.15% | 0.00% |
| March 12, 2024 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy)uy) | 29400 | $0.00 | 29,400.0000 | 52,311,958 | 9999.99% | 0.06% |
| March 12, 2024 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy)uy) | 29400 | $0.00 | 29,400.0000 | 52,311,958 | 9999.99% | 0.06% |
| March 5, 2024 | vTv Therapeutics Inc. | $VTVT | BAKER BROS. ADVISORS LP | Not found | A | Prefunded Warrants | 52925 | $0.00 | 2,823,061.0000 | 2,084,973 | 1.91% | 2.54% |
| March 5, 2024 | vTv Therapeutics Inc. | $VTVT | BAKER BROS. ADVISORS LP | Not found | D | Common Stock | 4776 | $0.00 | 8,060.0000 | 2,084,973 | 37.21% | 0.23% |
| March 5, 2024 | vTv Therapeutics Inc. | $VTVT | BAKER BROS. ADVISORS LP | Not found | D | Common Stock | 52881 | $0.00 | 89,254.0000 | 2,084,973 | 37.20% | 2.54% |
| March 5, 2024 | vTv Therapeutics Inc. | $VTVT | BAKER BROS. ADVISORS LP | Not found | A | Prefunded Warrants | 4780 | $0.00 | 254,948.0000 | 2,084,973 | 1.91% | 0.23% |
| Dec. 29, 2023 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 556 | $0.00 | 3,562,903.0000 | 223,958,000 | 0.02% | 0.00% |
| Dec. 29, 2023 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 554 | $0.00 | 314,452.0000 | 41,543,954 | 0.18% | 0.00% |
| Dec. 29, 2023 | IGM Biosciences, Inc. | $IGMS | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 554 | $0.00 | 3,390,877.0000 | 41,543,954 | 0.02% | 0.00% |
| Dec. 29, 2023 | INCYTE CORP | $INCY | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 556 | $0.00 | 34,040,811.0000 | 223,958,000 | 0.00% | 0.00% |
| June 30, 2023 | Kodiak Sciences Inc. | $KOD | BAKER BROS. ADVISORS LP | Director | A | Non-Qualified Stock Options (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | Kodiak Sciences Inc. | $KOD | BAKER BROS. ADVISORS LP | Director | A | Non-Qualified Stock Options (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | BAKER BROS. ADVISORS LP | Director | A | Non-Qualified Share Option (right to buy) | 52472 | $0.00 | 52,472.0000 | 69,751,697 | 9999.99% | 0.08% |
| June 6, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | BAKER BROS. ADVISORS LP | Director | A | Non-Qualified Share Option (right to buy) | 52472 | $0.00 | 52,472.0000 | 69,751,697 | 9999.99% | 0.08% |
| June 6, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | BAKER BROS. ADVISORS LP | Director | A | Class A Common Shares | 8746 | $0.00 | 147,406.0000 | 69,751,697 | 6.31% | 0.01% |
| June 6, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | BAKER BROS. ADVISORS LP | Director | A | Class A Common Shares | 8746 | $0.00 | 2,749,023.0000 | 69,751,697 | 0.32% | 0.01% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | A | Common Stock | 13304 | $0.00 | 3,829,499.0000 | 161,683,000 | 0.35% | 0.01% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | A | Non-Qualified Stock Options (right to buy) | 22090 | $0.00 | 22,090.0000 | 161,683,000 | 50.00% | 0.01% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | A | Common Stock | 13304 | $0.00 | 39,536,729.0000 | 161,683,000 | 0.03% | 0.01% |
| May 24, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | P | Common Stock | 259109 | $25.65 | 39,523,425.0000 | 161,683,000 | 0.66% | 0.16% |
| May 22, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | P | Common Stock | 7645 | $24.46 | 3,735,010.0000 | 161,683,000 | 0.21% | 0.00% |
| May 22, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | P | Common Stock | 82148 | $24.46 | 38,772,881.0000 | 161,683,000 | 0.21% | 0.05% |
| May 22, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | P | Common Stock | 3781 | $24.80 | 3,738,791.0000 | 161,683,000 | 0.10% | 0.00% |
| May 22, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | P | Common Stock | 40632 | $24.80 | 38,813,513.0000 | 161,683,000 | 0.10% | 0.03% |
| May 23, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | M | Common Stock | 12500 | $17.01 | 3,751,291.0000 | 161,683,000 | 0.33% | 0.01% |
| May 23, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | M | Common Stock | 12500 | $17.01 | 38,826,013.0000 | 161,683,000 | 0.03% | 0.01% |
| May 23, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | P | Common Stock | 10858 | $25.33 | 3,762,149.0000 | 161,683,000 | 0.29% | 0.01% |
| May 23, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | P | Common Stock | 116672 | $25.33 | 38,942,685.0000 | 161,683,000 | 0.30% | 0.07% |
| May 23, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | P | Common Stock | 6941 | $25.54 | 3,769,090.0000 | 161,683,000 | 0.18% | 0.00% |
| May 23, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | P | Common Stock | 74582 | $25.54 | 39,017,267.0000 | 161,683,000 | 0.19% | 0.05% |
| May 24, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | P | Common Stock | 20304 | $25.27 | 3,789,394.0000 | 161,683,000 | 0.54% | 0.01% |
| May 24, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | P | Common Stock | 218171 | $25.27 | 39,235,438.0000 | 161,683,000 | 0.56% | 0.13% |
| May 24, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | P | Common Stock | 2688 | $25.51 | 3,792,082.0000 | 161,683,000 | 0.07% | 0.00% |
| May 24, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | P | Common Stock | 28878 | $25.51 | 39,264,316.0000 | 161,683,000 | 0.07% | 0.02% |
| May 24, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | P | Common Stock | 24113 | $25.65 | 3,816,195.0000 | 161,683,000 | 0.64% | 0.01% |
| May 23, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | M | Non-Qualified Stock Options (right to buy) | 12500 | $0.00 | 0.0000 | 161,683,000 | 100.00% | 0.01% |
| May 23, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | M | Non-Qualified Stock Options (right to buy) | 12500 | $0.00 | 0.0000 | 161,683,000 | 100.00% | 0.01% |
| Jan. 12, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | M | Non-Qualified Stock Options (right to buy) | 15000 | $0.00 | 0.0000 | 161,683,000 | 100.00% | 0.01% |
| Jan. 12, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | M | Non-Qualified Stock Options (right to buy) | 15000 | $0.00 | 0.0000 | 161,683,000 | 100.00% | 0.01% |
| Jan. 12, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | M | Common Stock | 15000 | $5.22 | 38,690,733.0000 | 161,683,000 | 0.04% | 0.01% |
| Jan. 12, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | BAKER BROS. ADVISORS LP | Director | M | Common Stock | 15000 | $5.22 | 3,727,365.0000 | 161,683,000 | 0.40% | 0.01% |